Initial experience with biosimillar insulin glargine 100 IU/ml – Semglee® insulin: a case report
Authors:
Alena Gabrišová
Authors‘ workplace:
Diabetes centrum s. r. o., Trenčín
Published in:
Diab Obez 2019; 19(38): 127-129
Category:
Sources
- Martinka E, Uličiansky V, Mokáň M et al. Konsenzuálne terapeutické odporúčanie Slovenskej diabetologickej spoločnosti pre diabetes mellitus 2. typu (2018). Forum Diab 2018; 7(1): 47–68.
- Pelikánová T, Bartoš V et al. Praktická diabetologie 6. ed. Maxdorf: Praha 2018. ISBN 978–80–7345–559–0.
Labels
Diabetology ObesitologyArticle was published in
Diabetes a obezita
2019 Issue 38
Most read in this issue
- Vliv léčby inzulinem Fiasp na glykemie, HbA1c a tělesnou hmotnost u osob s diabetem 1. a 2. typu: studie z reálné praxe
- Has everything really been discovered about SGLT2 inhibitors?
- Early insulin treatment of a newly diagnosed type 2 diabetic patient: a case report
- Gut microbiome in children and risk of developing type 1 diabetes mellitus